Journal of Chromatography A, Journal Year: 2024, Volume and Issue: 1742, P. 465651 - 465651
Published: Dec. 31, 2024
Language: Английский
Journal of Chromatography A, Journal Year: 2024, Volume and Issue: 1742, P. 465651 - 465651
Published: Dec. 31, 2024
Language: Английский
Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 245, P. 114285 - 114285
Published: Sept. 30, 2024
Language: Английский
Citations
7International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 279, P. 135201 - 135201
Published: Aug. 30, 2024
Language: Английский
Citations
5Biomaterials Science, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Localised cytokine delivery is a promising strategy for modulating immune response and enhancing regenerative medicine therapies. SPAK-PEGDA hydrogels enable the long-term controlled release of lysozyme sustained Interleukin-4.
Language: Английский
Citations
0ACS Applied Materials & Interfaces, Journal Year: 2025, Volume and Issue: unknown
Published: April 10, 2025
Protein drugs have garnered increasing attention in biomedical applications due to their high specificity for target receptors and minimal side effects. However, the macromolecular hydrophilic nature of proteins severely hinders ability penetrate cell membranes, restricting intracellular applications. Herein, we present an innovative amphiphilic cationic polymer, p(PG420-co-HP15), capable forming stable nanoparticles with diverse facilitating efficient cytosolic delivery. By incorporating guanidinium phenyl ligands, p(PG420-co-HP15) effectively complexes various via hydrogen bonding, salt bridges, hydrophobic π-π interactions. Meanwhile, ligands further enhance cellular uptake promote endosomal escape by inducing membrane perturbations, likely through disruption phospholipid packing increased fluidity. Consequently, enables delivery 6 proteins, each unique molecular weights, isoelectric points, biological functions across different lines, surpassing commercial reagent PULSin efficiency. Furthermore, constructed nanovaccines ovalbumin (OVA), significantly boosting T cell-mediated antitumor immunity a B16-OVA melanoma mouse model. These findings emphasize potential as versatile protein platform broad disease treatment, vaccine development, research.
Language: Английский
Citations
0Carbohydrate Polymer Technologies and Applications, Journal Year: 2024, Volume and Issue: 8, P. 100622 - 100622
Published: Nov. 28, 2024
Language: Английский
Citations
3International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 277, P. 134535 - 134535
Published: Aug. 5, 2024
Language: Английский
Citations
2Journal of Chromatography A, Journal Year: 2024, Volume and Issue: 1742, P. 465651 - 465651
Published: Dec. 31, 2024
Language: Английский
Citations
0